Topic: Biobot Analytics

Former FDA Commissioner Scott Gottlieb discusses the "Eris" (EG.5) variant on CNBC, noting its ability to escape prior immunity while remaining less pathogenic than previous strains. Gottlieb emphasizes the importance of wastewater data from BioBot Analytics due to the unreliability of home testing and state reporting. The hosts criticize Gottlieb's ties to Pfizer and the potential for wastewater surveillance to be used for social control.

BioBot Analytics co-founder Newsha Ghaeli describes the company's technology for analyzing sewage to create a global human health database. Originally focused on the opioid epidemic, the system can geolocate drug use and infectious diseases down to specific neighborhoods or buildings. The hosts compare the company's pitch to the Theranos scandal and raise significant privacy concerns regarding the tracking of pharmaceutical and illicit drug consumption.